Information Provided By: 
Fly News Breaks for January 11, 2016
CELG
Jan 11, 2016 | 11:59 EDT
Jefferies analyst Brian Abrahams said Celgene's 2016 guidance was roughly in-line with consensus expectations and noted that the company tends to guide conservatively. The analyst, who expects the company's CEO transition to be a smooth one, continues to views the stock as undervalued given its long-term opportunity and recommends the shares be bought on weakness. Abrahams keeps a Buy rating and $149 price target on Celgene shares, which are down over 6% to $102 near midday.
News For CELG From the Last 2 Days
There are no results for your query CELG
